Sanjay Kumar

A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial.

M. Sahay, M. Westerman, S. Roger, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Exploring the Potential of RET Kinase Inhibition for Irritable Bowel Syndrome: A Preclinical Investigation in Rodent Models of Colonic Hypersensitivity

M. Gershon, B. Greenwood-Van Meerveld, M. Cheung, 2018, The Journal of Pharmacology and Experimental Therapeutics.

Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS.

G. Joberty, N. Zinn, M. Cheung, 2018, ACS medicinal chemistry letters.

Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma

D. Behm, J. Throup, A. Portnoy, 2013, Front. Pharmacol..

Discovery of Orally Bioavailable Ligand Efficient Quinazolindiones as Potent and Selective Tankyrases Inhibitors.

R. Keenan, M. Cheung, A. Oliff, 2021, ACS medicinal chemistry letters.

Enteric RET inhibition attenuates gastrointestinal secretion and motility via cholinergic signaling in rat colonic mucosal preparations

R. Latorre, B. Greenwood-Van Meerveld, M. Cheung, 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

A Novel Acyl-CoA: Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor, GSK2973980A, Inhibits Postprandial Triglycerides and Reduces Body Weight in a Rodent Diet-induced Obesity Model

Douglas W. Thomson, G. Bergamini, A. Awasthi, 2017 .